Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 13 Pancreatic Neoplasms 6 Breast Neoplasms 6 Ovarian Neoplasms 4 Uterine Cervical Neoplasms 3 Multiple Myeloma 3 Melanoma 3 Lymphoma 3 Thyroid Diseases 2 Prostatic Neoplasms 2 Pancreatic Cyst 2 Neoplasm Metastasis 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Wilms Tumor 1 Venous Thrombosis 1 Venous Thromboembolism 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thrombosis 1 Testicular Neoplasms 1

Interventions

Nivolumab 74 Sunitinib 73 pembrolizumab 49 Everolimus 39 Sorafenib 36 Bevacizumab 36 Axitinib 36 cabozantinib 35 Radiosurgery 33 Ipilimumab 33 pazopanib 32 Magnetic Resonance Spectroscopy 27 Interleukin-2 27 aldesleukin 23 Specimen Handling 22 Cyclophosphamide 21 lenvatinib 20 fludarabine phosphate 17 Radiotherapy 16 Interferon-alpha 15 Peripheral Blood Stem Cell Transplantation 14 Gemcitabine 14 Biopsy 14 temsirolimus 13 Nephrectomy 13 durvalumab 11 Immunohistochemistry 11 CTLA-4 Antigen 11 Blood Specimen Collection 11 Capecitabine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Renal Cell × Data Collection × Clear all

NCT05456074 2022-11-25

IMCOR

Institut de cancérologie Strasbourg Europe

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡